{
  "id": 9777117,
  "title": "Merck's diabetes-related eye drug passed a late-stage trial, but safety questions linger",
  "url": "https://urgent.news/2026/09/25/mercks-diabetes-related-eye-drug-passed-a-late-stage-trial-but-safety",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T13:40:33.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/merck-remigromig-eye-disease-trial-safety-092526"
  },
  "original_language": "en",
  "account": null,
  "summary": "Remigromig matched a standard treatment for diabetic macular edema in a late-stage study, but showed higher rates of certain retinal complications",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}